Chimeric Therapeutics Ltd (CHM) — Cash Flow Quality Index

Latest as of December 2023: -3.81x

Chimeric Therapeutics Ltd (CHM) has a Cash Flow Quality Index of -3.81x as of December 2023. Operating cash flow of AU$-4.66 Million is below net income of AU$1.22 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Chimeric Therapeutics Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-3.81x

Operating CF / Net Income

Operating Cash Flow

AU$-4.66 Million

AUD

Net Income

AU$1.22 Million

AUD

Data as of

Dec 2023

Most recent filing

Annual Cash Flow Quality Index for Chimeric Therapeutics Ltd (None–None)

Year-by-year earnings quality comparison for Chimeric Therapeutics Ltd. For live market cap and the full company financial profile, see Chimeric Therapeutics Ltd market cap and net worth.

Year	Quality Index	Operating CF (AUD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.